Sarah Tizzard
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Sarah Tizzard has a total of 55 co-authors. Here are the top co-authors by number of shared publications:
Giorgina Mieli-Vergani
Department of Child Health, King's College London School of Medicine at King's College Hospital, London, United Kingdom
4 shared publications- Mark Davenport
Department of Paediatric Surgery, King's College Hospital, London, SE5 9RS, UK
3 shared publications Nedim Hadzic
Paediatric Gastrointestinal, Liver and Nutrition Centre Variety Children's Hospital King's College Hospital NHS Foundation Trust Denmark Hill Camberwell London UK
3 shared publications- Nedim Hadzic
King's College Hospital London UK
3 shared publications - Giorgina Mieli-Vergani
Institute of Liver Studies, MowatLabs, Department of Inflammation Biology, School of Immunology & Microbial Sciences, Faculty of Liver Sciences and Medicine King's College London London UK
2 shared publications Mark Davenport
Departments of *Child Health and †Paediatric Surgery, King's College Hospital, Denmark Hill, London, United Kingdom
2 shared publications
Latest Publications
- 8 January 2019
- Published by Royal College of Nursing in Nursing Children and Young People
- Vol. 31 (1) , 17
Nurses should contribute to public policy to reduce inequalities in children’s health
This study highlights the importance of longitudinal cohort studies, which can document and demonstrate changes over time in defined populations. By combining data from the cohort studies, the authors show a significant change in the pattern of socio-economic inequalities in childhood and adolescent body weight and BMI during 1953-2015.
- 8 January 2019
- Published by Royal College of Nursing in Nursing Children and Young People
- Vol. 31 (1) , 17
Nurses should contribute to public policy to reduce inequalities in children’s health
This study highlights the importance of longitudinal cohort studies, which can document and demonstrate changes over time in defined populations. By combining data from the cohort studies, the authors show a significant change in the pattern of socio-economic inequalities in childhood and adolescent body weight and BMI during 1953-2015.
- 8 October 2015
- Published by Royal College of Nursing in Nursing Children and Young People
- Vol. 27 (8) , 11
Click
This month we look at why you should be using Twitter OXFORD UNIVERSITY Press analysed the writing of children under the age of 13 and found ‘hashtag’ to be their word of the year (tinyurl.com/plsrl3y). If hashtag (#) is the favoured word of the children and young people that we care for, it needs to be in our vocabulary too.
- 8 October 2015
- Published by Royal College of Nursing in Nursing Children and Young People
- Vol. 27 (8) , 11
Click
This month we look at why you should be using Twitter OXFORD UNIVERSITY Press analysed the writing of children under the age of 13 and found ‘hashtag’ to be their word of the year (tinyurl.com/plsrl3y). If hashtag (#) is the favoured word of the children and young people that we care for, it needs to be in our vocabulary too.
- 1 June 2015
- Published by Elsevier in Clinics and Research in Hepatology and Gastroenterology
- Vol. 39 (3) , 292-295
“Current state and prospects in managing liver transplanted children”
- 1 June 2015
- Published by Elsevier in Clinics and Research in Hepatology and Gastroenterology
- Vol. 39 (3) , 292-295
“Current state and prospects in managing liver transplanted children”
- 1 April 2015
- Published by Wiley in Journal of Pediatric Gastroenterology and Nutrition
- Vol. 60 (4) , 550-561
Indications and Limitations of Bariatric Intervention in Severely Obese Children and Adolescents With and Without Nonalcoholic Steatohepatitis
Morbid obesity is strongly associated with nonalcoholic fatty liver disease (NAFLD), which is one of the most common causes of chronic liver disease worldwide. The present best treatment for NAFLD and nonalcoholic steatohepatitis (NASH) is weight reduction through lifestyle modification. Because of frustrating inefficiency of such a therapeutic approach, bariatric surgery is increasingly performed in adolescents as an alternative option for weight reduction. Standards of care and consensus for indications are, however, scarce. We explore the indications and limitations of bariatric surgery in children with severe obesity with and without NASH and aim to provide guidance for the exceptional indications for adolescents with extreme obesity with major comorbidity that may benefit from these controversial interventions. Present evidence suggests that bariatric surgery can decrease the grade of steatosis, hepatic inflammation, and fibrosis in NASH. Uncomplicated NAFLD is not an indication for bariatric surgery. Roux‐en‐Y gastric bypass is considered a safe and effective option for adolescents with extreme obesity, as long as an appropriate long‐term follow‐up is provided. Laparoscopic adjustable gastric banding has not been approved by the Food and Drug Administration for use in adolescents and therefore should be considered investigational. Finally, sleeve gastrectomy and other types of weight loss surgery that have grown increasingly common in adults, still need to be considered investigational. Temporary devices may be increasingly being used in pediatrics; however, future studies, including a long‐term risk analysis of patients who undergo surgery, are much needed to clarify the exact indications for bariatric surgery in adolescents.
- 1 April 2015
- Published by Wiley in Journal of Pediatric Gastroenterology and Nutrition
- Vol. 60 (4) , 550-561
Indications and Limitations of Bariatric Intervention in Severely Obese Children and Adolescents With and Without Nonalcoholic Steatohepatitis
Morbid obesity is strongly associated with nonalcoholic fatty liver disease (NAFLD), which is one of the most common causes of chronic liver disease worldwide. The present best treatment for NAFLD and nonalcoholic steatohepatitis (NASH) is weight reduction through lifestyle modification. Because of frustrating inefficiency of such a therapeutic approach, bariatric surgery is increasingly performed in adolescents as an alternative option for weight reduction. Standards of care and consensus for indications are, however, scarce. We explore the indications and limitations of bariatric surgery in children with severe obesity with and without NASH and aim to provide guidance for the exceptional indications for adolescents with extreme obesity with major comorbidity that may benefit from these controversial interventions. Present evidence suggests that bariatric surgery can decrease the grade of steatosis, hepatic inflammation, and fibrosis in NASH. Uncomplicated NAFLD is not an indication for bariatric surgery. Roux‐en‐Y gastric bypass is considered a safe and effective option for adolescents with extreme obesity, as long as an appropriate long‐term follow‐up is provided. Laparoscopic adjustable gastric banding has not been approved by the Food and Drug Administration for use in adolescents and therefore should be considered investigational. Finally, sleeve gastrectomy and other types of weight loss surgery that have grown increasingly common in adults, still need to be considered investigational. Temporary devices may be increasingly being used in pediatrics; however, future studies, including a long‐term risk analysis of patients who undergo surgery, are much needed to clarify the exact indications for bariatric surgery in adolescents.
- 1 June 2014
- Published by Elsevier in Clinics and Research in Hepatology and Gastroenterology
- Vol. 38 (3) , 277-283
Tips and hints for the transition: What adult hepatologists should know when accept teens with a pediatric hepatobiliary disease
- 1 June 2014
- Published by Elsevier in Clinics and Research in Hepatology and Gastroenterology
- Vol. 38 (3) , 277-283
Tips and hints for the transition: What adult hepatologists should know when accept teens with a pediatric hepatobiliary disease
- 3 February 2014
- Published by BMJ in Archives of Disease in Childhood
- Vol. 99 (6) , 505-510
Treatment of chronic viral hepatitis C in children and adolescents: UK experience
Aim To review the efficacy and tolerability of pegylated interferon-α and ribavirin for treatment of chronic hepatitis C (CHC) in children in the UK. Methods Retrospective review of children treated for CHC in 3 UK paediatric specialist liver centres between 2005 and 2010. Data on viral response to treatment, demographic and clinical details were collected. Treatment outcome was assessed by the absence of detectable viral RNA in blood 24 weeks after treatment—sustained viral response (SVR). Results 75 children were included; 34 genotype 1; 39 genotypes 2 and 3; 2 genotype 4. Overall SVR was achieved in 54/71 (76%); 65% genotype 1; 89% genotypes 2 and 3; 100% genotype 4. Early response at 12 weeks was achieved in 53 and sustained in 47 (89%). Data on rapid response after 4 weeks of treatment were available in 25; 17/25 (68%) responded and 16 of these (94%) achieved SVR. IL28 T/T genotype was associated with higher SVR. There were no significant changes in weight and height z scores from baseline compared with 24 weeks post-treatment follow-up. No child discontinued treatment due to side effects, although 43 required dose modification. Treatment affected quality of life (QoL) in the initial 12 weeks of treatment, which improved by the end of treatment. Conclusions Children respond well to therapy for CHC. Treatment was tolerated with minimal impact on QoL and no significant effect on growth. Knowledge of viral and IL28 genotypes and early viral response is useful to plan treatment in children and provide appropriate counselling.
- 3 February 2014
- Published by BMJ in Archives of Disease in Childhood
- Vol. 99 (6) , 505-510
Treatment of chronic viral hepatitis C in children and adolescents: UK experience
Aim To review the efficacy and tolerability of pegylated interferon-α and ribavirin for treatment of chronic hepatitis C (CHC) in children in the UK. Methods Retrospective review of children treated for CHC in 3 UK paediatric specialist liver centres between 2005 and 2010. Data on viral response to treatment, demographic and clinical details were collected. Treatment outcome was assessed by the absence of detectable viral RNA in blood 24 weeks after treatment—sustained viral response (SVR). Results 75 children were included; 34 genotype 1; 39 genotypes 2 and 3; 2 genotype 4. Overall SVR was achieved in 54/71 (76%); 65% genotype 1; 89% genotypes 2 and 3; 100% genotype 4. Early response at 12 weeks was achieved in 53 and sustained in 47 (89%). Data on rapid response after 4 weeks of treatment were available in 25; 17/25 (68%) responded and 16 of these (94%) achieved SVR. IL28 T/T genotype was associated with higher SVR. There were no significant changes in weight and height z scores from baseline compared with 24 weeks post-treatment follow-up. No child discontinued treatment due to side effects, although 43 required dose modification. Treatment affected quality of life (QoL) in the initial 12 weeks of treatment, which improved by the end of treatment. Conclusions Children respond well to therapy for CHC. Treatment was tolerated with minimal impact on QoL and no significant effect on growth. Knowledge of viral and IL28 genotypes and early viral response is useful to plan treatment in children and provide appropriate counselling.
- 1 November 2013
- Published by Royal College of Nursing in Nursing Children and Young People
- Vol. 25 (9) , 11
Click
- 1 November 2013
- Published by Royal College of Nursing in Nursing Children and Young People
- Vol. 25 (9) , 11
Click
- 1 November 2013
- Published by Elsevier in Journal of Hepatology
- Vol. 59 (5) , 1054-1058
Steroids in biliary atresia: Single surgeon, single centre, prospective study
- 1 November 2013
- Published by Elsevier in Journal of Hepatology
- Vol. 59 (5) , 1054-1058
Steroids in biliary atresia: Single surgeon, single centre, prospective study
- 1 January 2012
- Published by Pediatric Oncall Pvt Ltd in Pediatric Oncall
- Vol. 9 (9)
BILIARY ATRESIA AND KASAI`S SURGERY - WHEN IS IT TOO LATE
- 1 January 2012
- Published by Pediatric Oncall Pvt Ltd in Pediatric Oncall
- Vol. 9 (9)
BILIARY ATRESIA AND KASAI`S SURGERY - WHEN IS IT TOO LATE
- 2 September 2011
- Published by Royal College of Nursing in Nursing Children and Young People
- Vol. 23 (7) , 11
Indexes help to identify localities in need of healthcare interventions
- 2 September 2011
- Published by Royal College of Nursing in Nursing Children and Young People
- Vol. 23 (7) , 11
Indexes help to identify localities in need of healthcare interventions